West Nile virus infection in blood donors in the New York City area during the 2010 seasonal epidemic

Transfusion

Volumn 52, Issue 12, 2012, Pages 2664-2670

  Francis, Richard O ^a,b,c,d   Strauss, Donna ^a,b,c,d   Williams, Joan Dunn ^a,b,c,d   Whaley, Shavonne ^a,b,c,d   Shaz, Beth H ^a,b,c,d  

^a NEW YORK BLOOD CENTER   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c CREATIVE TESTING SOLUTIONS   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG; VIRUS ANTIBODY; WEST NILE FLAVIVIRUS ANTIBODY;

ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; CLINICAL ARTICLE; EPIDEMIC; FLAVIVIRUS INFECTION; HUMAN; INCIDENCE; SCREENING TEST; VIREMIA; WEST NILE FLAVIVIRUS;

ADULT; ALGORITHMS; ANIMALS; ANTIBODIES, VIRAL; BLOOD DONORS; BLOOD SAFETY; CULICIDAE; EPIDEMICS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INCIDENCE; NEW JERSEY; NEW YORK CITY; PUBLIC HEALTH; RETROSPECTIVE STUDIES; SEASONS; SEROEPIDEMIOLOGIC STUDIES; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84871006047     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03639.x     Document Type: Article

References (20)

1. Petersen LR, Marfin AA,. West Nile virus: a primer for the clinician. Ann Intern Med 2002; 137: 173-9.
2. Biggerstaff BJ, Petersen LR,. Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion 2002; 42: 1019-26.
3. Biggerstaff BJ, Petersen LR,. Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002. Transfusion 2003; 43: 1007-17.
4. Mather T, Takeda T, Tassello J, Ohagen A, Serebryanik D, Kramer E, Brown F, Tesh R, Alford B, Chapman J, Lazo A,. West Nile virus in blood: stability, distribution, and susceptibility to PEN110 inactivation. Transfusion 2003; 43: 1029-37.
5. Pealer LN, Marfin AA, Petersen LR, Lanciotti RS, Page PL, Stramer SL, Stobierski MG, Signs K, Newman B, Kapoor H, Goodman JL, Chamberland ME,. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003; 349: 1236-45.
6. Busch MP, Kleinman SH, Tobler LH, Kamel HT, Norris PJ, Walsh I, Matud JL, Prince HE, Lanciotti RS, Wright DJ, Linnen JM, Caglioti S,. Virus and antibody dynamics in acute West Nile virus infection. J Infect Dis 2008; 198: 984-93.
7. Montgomery SP, Brown JA, Kuehnert M, Smith TL, Crall N, Lanciotti RS, Macedo de Oliveira A, Boo T, Marfin AA,. Transfusion-associated transmission of West Nile virus, United States 2003 through 2005. Transfusion 2006; 46: 2038-46.
8. Custer B, Tomasulo PA, Murphy EL, Caglioti S, Harpool D, McEvoy P, Busch MP,. Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making. Transfusion 2004; 44: 1547-54.
9. Kleinman SH, Williams JD, Robertson G, Caglioti S, Williams RC, Spizman R, Morgan L, Tomasulo P, Busch MP,. West Nile virus testing experience in 2007: evaluation of different criteria for triggering individual-donation nucleic acid testing. Transfusion 2009; 49: 1160-70.
10. Biggerstaff BJ, Petersen LR,. A modeling framework for evaluation and comparison of trigger strategies for switching from minipool to individual-donation testing for West Nile virus. Transfusion 2009; 49: 1151-9.
11. Custer B, Busch MP, Marfin AA, Petersen LR,. The cost-effectiveness of screening the U.S. blood supply for West Nile virus. Ann Intern Med 2005; 143: 486-92.
12. Korves CT, Goldie SJ, Murray MB,. Cost-effectiveness of alternative blood-screening strategies for West Nile virus in the United States. PLoS Med 2006; 3: e21.
13. New York State Department of Health. West Nile virus update [monograph on the internet]. 2011. [cited 2011 Jun 30]. Available from: URL: http://www.health.state.ny.us/nysdoh/westnile/update/update.htm
14. Connor DJ, Lipton KS,. West-Nile virus-revised recommendations for triggering individual donation nucleic acid testing and use of communication plans. Association Bulletin No. 08-03. Bethesda (MD): American Association of Blood Banks; 2008.
15. Harrington T, Kuehnert MJ, Kamel H, Lanciotti RS, Hand S, Currier M, Chamberland ME, Petersen LR, Marfin AA,. West Nile virus infection transmitted by blood transfusion. Transfusion 2003; 43: 1018-22.
16. Macedo de Oliveira A, Beecham BD, Montgomery SP, Lanciotti RS, Linnen JM, Giachetti C, Pietrelli LA, Stramer SL, Safranek TJ,. West Nile virus blood transfusion-related infection despite nucleic acid testing. Transfusion 2004; 44: 1695-9.
17. Busch MP, Caglioti S, Robertson EF, McAuley JD, Tobler LH, Kamel H, Linnen JM, Shyamala V, Tomasulo P, Kleinman SH,. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N Engl J Med 2005; 353: 460-7.
18. Kleinman S, Glynn SA, Busch M, Todd D, Powell L, Pietrelli L, Nemo G, Schreiber G, Bianco C, Katz L,. The 2003 West Nile virus United States epidemic: the America's Blood Centers experience. Transfusion 2005; 45: 469-79.
19. Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP, Dodd RY,. West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med 2005; 353: 451-9.
20. Stramer SL, Foster G, Krysztof D, Dodd R,. Evaluation of triggering strategies for single unit NAT West Nile virus. Transfusion 2008; 48: 23A.